Highlights from ACR Convergence 2023
View American College of Rheumatology educational opportunities here - https://rheumatology.org/events-programs
ACR Convergence 2023 Highlights: Clinical Consequences of Infliximab Immunogenicity and the Impact of Proactive Therapeutic Drug Monitoring: Secondary Analyses of a Randomised Clinical Trial
By
Highlights from ACR Convergence 2023
FEATURING
Marthe Brun
By
Highlights from ACR Convergence 2023
FEATURING
Marthe Brun
The above content is not sponsored by, nor part of, the American College of Rheumatology. ...
read more ↘
read more ↘
Comments 0
Login to view comments.
Click here to Login
